Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From Aug 01, 2024

Nestle India Invests Rs 705 Crore In JV With Dr Reddy's Labs

Nestle India Invests Rs 705 Crore In JV With Dr Reddy's Labs
Nestlé India (NSE: NestléIND): Outlook & Valuation: 2024

Nestle India Ltd. invested Rs 705.5 crore in a joint venture with Dr Reddy's Laboratories Ltd. that caters to nutritional health solutions. The company subscribed 70.55 lakh equity shares of Dr. Reddy's and Nestlé Health Science Ltd. on a rights basis, according to an exchange filing on Thursday. Nestle India owns 49% of the JV.

A part of this investment will be used to fund the acquisition of Nestle India's existing medical nutrition and nutraceuticals business for Rs 218.9 crore. The food and beverage major executed a business transfer agreement for the slump sale.

Nestle India and Dr Reddy's announced their tie-up in April.

The joint venture will bring together the well-known global range of nutritional health solutions as well as vitamins, minerals and health supplements of Nestlé Health Science with the nutraceuticals portfolios, strong and established commercial strengths of DRL, Nestle India said.

The company was incorporated on March 14 of this year.

Shares of Nestle India closed 1.14% higher at Rs 2,484.05 apiece, ahead of the announcement, as compared to a 0.15% advance in the benchmark BSE Sensex.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search